PDCD1 and non-small cell lung carcinoma: Additionally, the levels of glutamate/glutamine, phenylalanine, n-acetyl-d-tryptophan and valine have been shown to be significantly increased in NSCLC patients after treatment with PD-1/PD-L1 inhibitors [41].